Paper - WANFANG MED ONLINE

You Position: Home > Paper

Advance in pathogenesis and treatment of liver fibrosis

( views:227, downloads:39 )

Author:: No author available

Journal Title:: WORLD CHINESE JOURNAL OF DIGESTOLOGY

Issue:: 23

DOI:: 10.3969/j.issn.1009-3079.2006.23.002

Key Word:: 肝脏疾病;纤维化发生学;药物治疗

Abstract：肝纤维化是各种致病原因引起细胞外基质(ECM)在肝内过多沉积的病理过程.在细胞和分子发病机制方面的研究显示,细胞因子作用于窦周间隙静止的肝星状细胞(HSC)使其转变为激活状态,继而增殖,合成ECM.因此认为激活的HSC是产生ECM的主要细胞,其他如肝静脉区成纤维细胞和骨髓源性肌成纤维细胞也是某些肝纤维化初期的主要纤维原性细胞.目前认为,进展性肝纤维化具有可逆性.药物旨在通过抑制HSC的激活、诱导其凋亡和防止ECM沉积的干预性治疗在实验性肝纤维化已取得疗效,但人类抗肝纤维化的有效性和安全性有待于进一步研究和论证.

Reference

[1]Michael J P, Arthur.Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C.[J].2002,122(5).
[2]Kumada Hiromitsu.Long-term treatment of chronic hepatitis C with glycyrrhizin (stronger neo-minophagen C (SNMC)) for preventing liver cirrhosis and hepatocellular carcinoma.[J].2002,62(Suppl.1).
[3]Gressner AM,Weiskirchen R.Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.[J].2006,10(1).
[4]Bataller R,Brenner DA.Liver fibrosis.[J].2005,115(2).
[5]Nagy P,Sanderson N,Wakefield L,etc.Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.[J].1995,92(7).
[6]Scott T, Magness,Ramón, Bataller,Liu, Yang,etc.A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.[J].2004,40.
[7]Jack R, Wands.Prevention of hepatocellular carcinoma.[J].2004,351(15).
[8]Gaca MD,Wells RG,Liu C,etc.Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent.[J].2003,278(13).
[9]Higuchi H,Gores GJ.Mechanisms of liver injury: an overview.[J].2003,3(6).
[10]Barjoan EM,Benzaken S,Calle G,etc.The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C.[J].2004,11(1).
[11]Melissa M. Odell,Debra G. Gilbertson,Harald S. Haugen,etc.Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma[J].2005,102(9).
[12]Li ZP,Lin HZ,Yang SQ,etc.Cytokines and the pathogenesis of non-alcoholic steatohepatitis.[J].2005,54(2).
[13]Pinzani M,Gesualdo L,Sabbah G M,etc.Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.[J].1989.
[14]I, Okazaki,T, Watanabe,S, Hozawa,etc.Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery.[J].2001,50(2).
[15]Moreno Otero R,Medina J,Fernandez Salazar LI,etc.Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.[J].2004,27(8).
[16]Erwin, G?bele,David A, Brenner,Richard A, Rippe.Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell.[J].2003,8.
[17]RC Benyon,JP Iredale,S Goddard,etc.Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver[J].1996,110(3).
[18]J P, Iredale.Tissue inhibitors of metalloproteinases in liver fibrosis.[J].1997,29(1).
[19]Brenner DA,Bataller R.Hepatic stellate cells as a target for the treatment of liver fibrosis.[J].2001,21(3).
[20]cpub.duke.edu,Rockey DC.Hepatic blood flow regulation by stellate cells in normal and injured liver.[J].2001,21(3).
[21]Van der Elst I,van Pelt JF,Roskams T,etc.Halofuginone can worsen liver fibrosis in bile duct obstructed rats.[J].2004,24(5).
[22]Kalluri R,Neilson EG.Epithelial-mesenchymal transition and its implications for fibrosis.[J].2003,112(12).
[23]Wells RG,Uemura M,Giordano FJ,etc.Smad2 and smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization[J].2005,16(9).
[24]Ishii G,Sugiyama K,Magae J,etc.In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions.[J].2005,23(5).
[25]Zavadil J,Bottinger EP.TGF-beta and epithelial-to-mesenchymal transitions.[J].2005,24(37).
[26]Bonvoust Franck,Paradis Valerie,Vidaud Michel,etc.Effects and regulation of connective tissue growth factor on hepatic stellate cells.[J].2002,82(6).
[27]Strieter RM,Murray LA,Keane MP,etc.Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.[J].2004,114(3).
[28]Bachem M G,Meyer D,Melchior R,etc.Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis.[J].1992.
[29]Schuppan D,Bauer M,Hahn EG,etc.Hepatitis C and liver fibrosis.[J].2003,10(Suppl.1).
[30]Schnabl B,Schwabe RF,Kweon YO,etc.CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.[J].2001,166(11).
[31]Ramadori G,Saile B.Portal tract fibrogenesis in the liver.[J].2004,84(2).
[32]P, Mathurin,J, Moussalli,J F, Cadranel,etc.Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.[J].1998,27.
[33]Helen L, Reeves,Scott L, Friedman.Activation of hepatic stellate cells--a key issue in liver fibrosis.[J].2002,7.
[34]Reindollar R,Rustgi VK,Albrecht JK,etc.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.[J].2001,358(9286).
[35]Fabio, Marra.Chemokines in liver inflammation and fibrosis.[J].2002,7.
[36]F, Marra,M C, Arrighi,M, Fazi,etc.Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat.[J].1999,30.
[37]Scott L, Friedman.Liver fibrosis -- from bench to bedside.[J].2003,38 Suppl 1.
[38]Bonner JC.Regulation of PDGF and its receptors in fibrotic diseases.[J].2004,15(4).
[39]K, Breitkopf,P, Godoy,L, Ciuclan,etc.TGF-beta/Smad signaling in the injured liver.[J].2006,44(1).
[40]Thomas Knittel,Dominik Kobold,Bernhard Saile,etc.Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential[J].1999,117(5).
[41]Schwabe RF,Bataller R,Brenner DA.Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration.[J].2003,285(5).
[42]Friedman SL.Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis.[J].2005,115(1).
[43]Arthur MJ,Benyon RC.Extracellular matrix degradation and the role of hepatic stellate cells.[J].2001,21(3).
[44]Bauer M,Ruehl M,Cho JJ,etc.Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1.[J].2001,35(3).
[45]Pinzani M.Liver fibrosis.[J].1999,21(4).